SCM
HQL
Saba Capital Management’s abrdn Life Sciences Investors HQL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38.7M | Sell |
3,017,539
-170,866
| -5% | -$2.19M | 0.91% | 18 |
|
|
2025
Q1 | $40.5M | Sell |
3,188,405
-241,618
| -7% | -$3.07M | 1.09% | 18 |
|
|
2024
Q4 | $45M | Buy |
3,430,023
+32
| +0% | +$420 | 1.05% | 19 |
|
|
2024
Q3 | $51.7M | Hold |
3,429,991
| – | – | 1.08% | 23 |
|
|
2024
Q2 | $48.6M | Buy |
3,429,991
+967,844
| +39% | +$13.7M | 0.81% | 22 |
|
|
2024
Q1 | $33.6M | Buy |
2,462,147
+1,040,847
| +73% | +$14.2M | 0.57% | 26 |
|
|
2023
Q4 | $19.1M | Buy |
1,421,300
+1,149,693
| +423% | +$15.5M | 0.38% | 53 |
|
|
2023
Q3 | $3.39M | Buy |
271,607
+134,644
| +98% | +$1.68M | 0.08% | 146 |
|
|
2023
Q2 | $1.85M | Buy |
+136,963
| New | +$1.85M | 0.05% | 208 |
|